Correlation Engine 2.0
Clear Search sequence regions


  • a357300 (1)
  • aminopeptidases (2)
  • cellular (1)
  • chlorobenzenes (2)
  • humans (2)
  • lipolysis (4)
  • MetAP2 (9)
  • mice (3)
  • obese mice (3)
  • rats (1)
  • receptor (1)
  • signal (1)
  • thermogenesis (1)
  • ucp1 (1)
  • weight (3)
  • weight gain (1)
  • Sizes of these terms reflect their relevance to your search.

    Inhibitors of methionine aminopeptidase 2 (MetAP2) have been shown to reduce body weight in obese mice and humans. The target tissue and cellular mechanism of MetAP2 inhibitors, however, have not been extensively examined. Using compounds with diverse chemical scaffolds, we showed that MetAP2 inhibition decreases body weight and fat mass and increases lean mass in the obese mice but not in the lean mice. Obesity is associated with catecholamine resistance and blunted β-adrenergic receptor signaling activities, which could dampen lipolysis and energy expenditure resulting in weight gain. In the current study, we examined effect of MetAP2 inhibition on brown adipose tissue and brown adipocytes. Norepinephrine increases energy expenditure in brown adipose tissue by providing fatty acid substrate through lipolysis and by increasing expression of uncoupled protein-1 (UCP1). Metabolomic analysis shows that in response to MetAP2 inhibitor treatment, fatty acid metabolites in brown adipose tissue increase transiently and subsequently decrease to basal or below basal levels, suggesting an effect on fatty acid metabolism in this tissue. Treatment of brown adipocytes with MetAP2 inhibitors enhances norepinephrine-induced lipolysis and energy expenditure, and prolongs the activity of norepinephrine to increase ucp1 gene expression and energy expenditure in norepinephrine-desensitized brown adipocytes. In summary, we showed that the anti-obesity activity of MetAP2 inhibitors can be mediated, at least in part, through direct action on brown adipocytes by enhancing β-adrenergic-signaling-stimulated activities. © 2019 Huang et al.

    Citation

    Huey-Jing Huang, Corine Holub, Paul Rolzin, James Bilakovics, Andrea Fanjul, Yoshinori Satomi, Artur Plonowski, Christopher J Larson, Pamela J Farrell. MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes. The Journal of biological chemistry. 2019 Jun 14;294(24):9567-9575

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 31048375

    View Full Text